佳兆業(01638.HK)及宏達控股長沙灣項目命名為「弦雅」
佳兆業(01638.HK)及宏達控股合資發展、位於長沙灣醫局街203號的項目命名為「弦雅」,佳兆業客戶及營銷部總經理助理王倩指出,項目共提供95伙,提供開放式及一房單位,分別佔六成及四成,亦有特色戶供買家選擇,預計最快下月有機會推售,而樓書則料最快月底上載,並最快下月初開放示範單位,價錢將參考同區新盤。
佳兆業傳媒及投資關係總經理蔡晉指,公司現時在港還有兩個項目,分別位於西營盤東邊街及屯門青山灣,現時東邊街項目正在清拆舊樓,而屯門項目則正申請移除樹木等,料到2022年才會面世。他又強調對香港市場感樂觀,會繼續尋找好的發展時機或機遇。(el/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.